GoHealth - GOCO Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" GOCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GOCO, but not buy additional shares or sell existing shares.
View GOCO analyst ratings or view top-rated stocks.

2 brokers have issued twelve-month price targets for GoHealth's stock. Their GOCO share price forecasts range from $7.00 to $14.00. On average, they expect the company's share price to reach $10.67 in the next year. This suggests that the stock has a possible downside of 34.5%.
View analysts price targets for GOCO or view top-rated stocks among Wall Street analysts.

GoHealth's stock was trading at $10.45 at the start of the year. Since then, GOCO stock has increased by 55.8% and is now trading at $16.28.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our GOCO earnings forecast.

GoHealth, Inc. (NASDAQ:GOCO) released its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.09. The business earned $211.73 million during the quarter, compared to analyst estimates of $202.82 million. GoHealth had a negative net margin of 23.54% and a negative trailing twelve-month return on equity of 17.36%. During the same period last year, the business earned $1.82 EPS.

GoHealth updated its FY 2023 earnings guidance on Thursday, March, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $750.00 million-$850.00 million, compared to the consensus revenue estimate of $971.04 million.

25 employees have rated GoHealth Chief Executive Officer Matthew Crummack on Glassdoor.com. Matthew Crummack has an approval rating of 90% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other GoHealth investors own include Tesla (TSLA), Alibaba Group (BABA), CVS Health (CVS), Honeywell International (HON), Moderna (MRNA), Raytheon Technologies (RTX), Walmart (WMT), Cisco Systems (CSCO), Intel (INTC) and Johnson & Johnson (JNJ).

(GOCO) raised $750 million in an initial public offering on Wednesday, July 15th 2020. The company issued 39,500,000 shares at $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley served as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

GoHealth trades on the NASDAQ under the ticker symbol "GOCO."

Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GOCO stock can currently be purchased for approximately $16.28.

GoHealth (NASDAQ:GOCO) has a market capitalization of $357.51 million and generates $631.67 million in revenue each year. The company earns $-148,710,000.00 in net income (profit) each year or ($17.4948) on an earnings per share basis.

The company employs 2,467 workers across the globe.

GoHealth's mailing address is 214 WEST HURON STREET, CHICAGO IL, 60654. The official website for the company is www.gohealth.com. The company can be reached via phone at 312-386-8200 or via email at ir@gohealth.com.